Clinical Trial Update: Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD) [Phase 2]

View source ↗

Summary

A Phase 2 trial update shows completion of a study evaluating YH1885L for non-erosive reflux disease, assessing safety, tolerability and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Reflux Disease

Drugs mentioned

• YH1885L

Snippet

Sponsor: Yuhan Corporation | Conditions: Non-erosive Reflux Disease | Phase 2 | Status: COMPLETED